190 related articles for article (PubMed ID: 2379152)
1. Characterization of the shed form of the human tumor-associated glycoprotein (TAG-72) from serous effusions of patients with different types of carcinomas.
Katari RS; Fernsten PD; Schlom J
Cancer Res; 1990 Aug; 50(16):4885-90. PubMed ID: 2379152
[TBL] [Abstract][Full Text] [Related]
2. Serological mapping of the TAG-72 tumor-associated antigen using 19 distinct monoclonal antibodies.
Kuroki M; Fernsten PD; Wunderlich D; Colcher D; Simpson JF; Poole DJ; Schlom J
Cancer Res; 1990 Aug; 50(16):4872-9. PubMed ID: 1696162
[TBL] [Abstract][Full Text] [Related]
3. Purification and composition of the human tumor-associated glycoprotein (TAG-72) defined by monoclonal antibodies CC49 and B72.3.
Sheer DG; Schlom J; Cooper HL
Cancer Res; 1988 Dec; 48(23):6811-8. PubMed ID: 3180090
[TBL] [Abstract][Full Text] [Related]
4. Generation and characterization of B72.3 second generation monoclonal antibodies reactive with the tumor-associated glycoprotein 72 antigen.
Muraro R; Kuroki M; Wunderlich D; Poole DJ; Colcher D; Thor A; Greiner JW; Simpson JF; Molinolo A; Noguchi P
Cancer Res; 1988 Aug; 48(16):4588-96. PubMed ID: 3396010
[TBL] [Abstract][Full Text] [Related]
5. Enhanced tumor binding using immunohistochemical analyses by second generation anti-tumor-associated glycoprotein 72 monoclonal antibodies versus monoclonal antibody B72.3 in human tissue.
Molinolo A; Simpson JF; Thor A; Schlom J
Cancer Res; 1990 Feb; 50(4):1291-8. PubMed ID: 2297774
[TBL] [Abstract][Full Text] [Related]
6. Tumor-associated glycoprotein (TAG-72) in ovarian carcinomas defined by monoclonal antibody B72.3.
Thor A; Gorstein F; Ohuchi N; Szpak CA; Johnston WW; Schlom J
J Natl Cancer Inst; 1986 Jun; 76(6):995-1006. PubMed ID: 3520078
[TBL] [Abstract][Full Text] [Related]
7. Influence of spatial configuration of carcinoma cell populations on the expression of a tumor-associated glycoprotein.
Horan Hand P; Colcher D; Salomon D; Ridge J; Noguchi P; Schlom J
Cancer Res; 1985 Feb; 45(2):833-40. PubMed ID: 3881173
[TBL] [Abstract][Full Text] [Related]
8. Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3.
Johnson VG; Schlom J; Paterson AJ; Bennett J; Magnani JL; Colcher D
Cancer Res; 1986 Feb; 46(2):850-7. PubMed ID: 3940648
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunolocalization of human carcinoma xenografts with B72.3 second generation monoclonal antibodies.
Colcher D; Minelli MF; Roselli M; Muraro R; Simpson-Milenic D; Schlom J
Cancer Res; 1988 Aug; 48(16):4597-603. PubMed ID: 3396011
[TBL] [Abstract][Full Text] [Related]
10. Applications of monoclonal antibodies in clinical cytology as exemplified by studies with monoclonal antibody B72.3. The George N. Papanicolaou award lecture.
Johnston WW
Acta Cytol; 1987; 31(5):537-56. PubMed ID: 3314301
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic advantage of high-affinity anticarcinoma radioimmunoconjugates.
Schlom J; Eggensperger D; Colcher D; Molinolo A; Houchens D; Miller LS; Hinkle G; Siler K
Cancer Res; 1992 Mar; 52(5):1067-72. PubMed ID: 1310638
[TBL] [Abstract][Full Text] [Related]
12. Combined immunohistochemical and autoradiographic analyses of antigen/antibody interactions in tumor xenograft models.
DePalatis LR; Johnson KA; Kaplan DA
Lab Invest; 1991 Jul; 65(1):111-20. PubMed ID: 2072661
[TBL] [Abstract][Full Text] [Related]
13. Fractionated radioimmunotherapy of human colon carcinoma xenografts with 131I-labeled monoclonal antibody CC49.
Buchsbaum D; Khazaeli MB; Liu T; Bright S; Richardson K; Jones M; Meredith R
Cancer Res; 1995 Dec; 55(23 Suppl):5881s-5887s. PubMed ID: 7493364
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic characterization of lung cancers in fine needle aspiration biopsies using monoclonal antibody B72.3.
Johnston WW; Szpak CA; Thor A; Schlom J
Cancer Res; 1986 Dec; 46(12 Pt 1):6462-70. PubMed ID: 3022920
[TBL] [Abstract][Full Text] [Related]
15. Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3.
Thor A; Ohuchi N; Szpak CA; Johnston WW; Schlom J
Cancer Res; 1986 Jun; 46(6):3118-24. PubMed ID: 3516392
[TBL] [Abstract][Full Text] [Related]
16. Sialyl-dimeric Lewis-X antigen expressed on mucin-like glycoproteins in colorectal cancer metastases.
Matsushita Y; Cleary KR; Ota DM; Hoff SD; Irimura T
Lab Invest; 1990 Dec; 63(6):780-91. PubMed ID: 1979361
[TBL] [Abstract][Full Text] [Related]
17. Modulation of human tumor antigen expression.
Greiner JW; Hand PH; Colcher D; Weeks M; Thor A; Noguchi P; Pestka S; Schlom J
J Lab Clin Med; 1987 Mar; 109(3):244-61. PubMed ID: 2434589
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the colorectal carcinoma-associated antigen defined by monoclonal antibody D612.
Fernsten PD; Primus FJ; Greiner JW; Simpson JF; Schlom J
Cancer Res; 1991 Feb; 51(3):926-34. PubMed ID: 1988133
[TBL] [Abstract][Full Text] [Related]
19. The use of monoclonal antibody B72.3 in the management of gynecologic malignancies.
Simpson J; Schlom J
Yale J Biol Med; 1988; 61(4):351-66. PubMed ID: 3055701
[TBL] [Abstract][Full Text] [Related]
20. Improved radioimmunotherapeutic efficacy of an anticarcinoma monoclonal antibody (131I-CC49) when given in combination with gamma-interferon.
Greiner JW; Ullmann CD; Nieroda C; Qi CF; Eggensperger D; Shimada S; Steinberg SM; Schlom J
Cancer Res; 1993 Feb; 53(3):600-8. PubMed ID: 8425194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
